CoChat

Serum Cell Death Biomarkers for Prediction of Liver Fibrosis and Poor Prognosis in Primary Biliary Cirrhosis

Open access

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Abstract

The development of simple, noninvasive markers of liver fibrosis is urgently needed for primary biliary cirrhosis (PBC). This study examined the ability of several serum biomarkers of cell death to estimate fibrosis and prognosis in PBC. A cohort of 130 patients with biopsy-proven PBC and 90 healthy subjects were enrolled. We assessed the utility of the M30 ELISA, which detects caspase-cleaved cytokeratin-18 (CK-18) fragments and is representative of apoptotic cell death, as well as the M65 and newly developed M65 Epideath (M65ED) ELISAs, which detect total CK-18 as indicators of overall cell death, in predicting clinically relevant fibrosis stage. All 3 cell death biomarkers were significantly higher in patients with PBC than in healthy controls and were significantly correlated with fibrosis stage. The areas under the receiver operating characteristic curve for the M65 and M65ED assays for differentiation among significant fibrosis, severe fibrosis, and cirrhosis were 0.66 and 0.76, 0.66 and 0.73, and 0.74 and 0.82, respectively. In multivariate analysis, high M65ED (hazard ratio 6.13; 95% confidence interval 1.18-31.69; P = 0.031) and severe fibrosis (hazard ratio 7.45; 95% confidence interval 1.82-30.51; P = 0.005) were independently associated with liver-related death, transplantation, or decompensation. High serum M65ED was also significantly associated with poor outcome in PBC (log-rank test; P = 0.001). Noninvasive cell death biomarkers appear to be clinically useful in predicting fibrosis in PBC. Moreover, the M65ED assay may represent a new surrogate marker of adverse disease outcome.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0131658

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Correlation of the cell death biomarkers (A) M30, (B) M65, and (C) M65ED with liver fibrosis scores in primary biliary cirrhosis. Boxes represent the interquartile range (IQR) of the data. The lines across the boxes indicate the median values. Hash marks depict the nearest value within 1.5 times the IQR. Open circles indicate outliers. Detection by M30 (A) and M65 (B) was unable to significantly discriminate between F0-F3 and F4 fibrosis stages but could differentiate between F0-1 and ≥F2 or F0-2 and ≥F3 stages of fibrosis. Estimation using M65ED could significantly discriminate between all fibrosis stages.
Fig 1 Correlation of the cell death biomarkers (A) M30, (B) M65, and (C) M65ED with liver fibrosis scores in primary biliary cirrhosis. Boxes represent the interquartile range (IQR) of the data. The lines across the boxes indicate the median values. Hash marks depict the nearest value within 1.5 times the IQR. Open circles indicate outliers. Detection by M30 (A) and M65 (B) was unable to significantly discriminate between F0-F3 and F4 fibrosis stages but could differentiate between F0-1 and ≥F2 or F0-2 and ≥F3 stages of fibrosis. Estimation using M65ED could significantly discriminate between all fibrosis stages.CC BY · PubMed Central
Fig 2 Receiver operating characteristic analysis of the 3 cell death biomarkers (M30, M65, and M65ED) for the prediction of (A) significant fibrosis (≥F2), (B) severe fibrosis (≥F3), and (C) cirrhosis (F4).
Fig 2 Receiver operating characteristic analysis of the 3 cell death biomarkers (M30, M65, and M65ED) for the prediction of (A) significant fibrosis (≥F2), (B) severe fibrosis (≥F3), and (C) cirrhosis (F4).CC BY · PubMed Central
Fig 3 Cumulative survival rate analyzed using the Kaplan-Meier method according to baseline M65ED levels. Survival was significantly lower in patients when M65ED level was ≥ 672 U/L (P = 0.001).
Fig 3 Cumulative survival rate analyzed using the Kaplan-Meier method according to baseline M65ED levels. Survival was significantly lower in patients when M65ED level was ≥ 672 U/L (P = 0.001).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 39 references

Cited by

See all 27

Metadata

Authors
Sekiguchi, T., Umemura, T., Fujimori, N., Shibata, S., Ichikawa, Y., Kimura, T., Joshita, S., Komatsu, M., Matsumoto, A., Tanaka, E., & Ota, M.
Affiliations
Shinshu University (JP)
Corresponding author
Umemura, Takeji
Venue
PLOS ONE
Published
2015-06-25
Volume
10
Issue
6
Pages
e0131658
ISSN
1932-6203 (ISSN-L)
OpenAlex
W828765355
Cited by
27
References
39
Citations by year
2025: 2 · 2024: 1 · 2023: 1 · 2022: 3 · 2021: 1 · 2020: 5 · 2019: 1 · 2018: 3 · 2017: 3 · 2016: 6 · 2015: 1
FWCI
2.56
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Japan Society for the Promotion of Science (15H01803, 26460996)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
Keywords
primary biliary cirrhosis, liver fibrosis, cell death biomarkers, cytokeratin 18, apoptosis, noninvasive fibrosis staging, prognosis, liver-related mortality, liver transplantation, hepatic decompensation
MeSH terms
Aged, Biopsy, Enzyme-Linked Immunosorbent Assay, Female, Humans, Japan, Liver Cirrhosis, Liver Cirrhosis, Biliary, Male, Middle Aged, Prognosis, ROC Curve, Biomarkers, Case-Control Studies, Treatment Outcome, Cell Death, Apoptosis, Kaplan-Meier Estimate, Keratin-18

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Serum Cell Death Biomarkers for Prediction of Liver Fibrosis and Poor Prognosis in Primary Biliary Cirrhosis. https://app.cochat.ai/papers/10.1371/journal.pone.0131658
The paper
Sekiguchi, T., Umemura, T., Fujimori, N., Shibata, S., Ichikawa, Y., Kimura, T., Joshita, S., Komatsu, M., Matsumoto, A., Tanaka, E., & Ota, M. (2015). Serum Cell Death Biomarkers for Prediction of Liver Fibrosis and Poor Prognosis in Primary Biliary Cirrhosis. PLOS ONE. https://doi.org/10.1371/journal.pone.0131658

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.